Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Salivary Gland Neoplasms × spartalizumab × 30 days × Clear all

Sponsor

Conditions

Uterine Cervical Neoplasms 2 Carcinoma, Renal Cell 2 von Hippel-Lindau Disease 1 Solid Tumors 1 Prostatic Neoplasms 1 Pheochromocytoma 1 Paraganglioma 1 Hereditary leiomyomatosis and renal cell cancer 1 Glioma 1 Endometrial Neoplasms 1 Diffuse Intrinsic Pontine Glioma 1

Interventions

Carboplatin 3 trastuzumab deruxtecan 2 Docetaxel 2 Cisplatin 2 zanidatamab 1 sacituzumab govitecan 1 pembrolizumab 1 entrectinib 1 dehydroftorafur 1 ceralasertib 1 Specimen Handling 1 Sorafenib 1 Radiation 1 Platinum 1 Oral Hygiene 1 Maytansine 1 Magnetic Resonance Spectroscopy 1 Immunoglobulin G 1 Fluorouracil 1 Disulfides 1 Cetuximab 1 Biopsy 1 Bevacizumab 1 Ado-Trastuzumab Emtansine 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡